Clinical Trial Update: Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating rotation or switching of biotherapies after failure of initial anti-TNF therapy in rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED